Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kaiya

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|May 1, 1972
[Clinical and pathological observations on presenile dementia associated with amyotrophic lateral sclerosis-like symptoms]H Kaiya
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1990
CT findings in schizophreniaH Kaiya
Journal of Clinical Psychopharmacology|October 1, 1987
Prostaglandin E1 treatment of schizophreniaH Kaiya
Rinsho Shinkeigaku = Clinical Neurology|December 1, 1995
[Psycho-social effects of DNA diagnosis]H Kaiya
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1992
Second messenger imbalance hypothesis of schizophreniaH Kaiya
Biological Psychiatry|March 1, 1984
Prostaglandin E1 treatment of schizophreniaH Kaiya
Neuropsychobiology|January 1, 1980
Neuromelanin, neuroleptics and schizophrenia: hypothesis of an interaction between noradrenergic and dopaminergic systemH Kaiya
Schizophrenia Research|July 1, 1991
Prostaglandin E1 suppression of platelet aggregation response in schizophreniaH Kaiya
The American Journal of Psychiatry|January 1, 1990
Another neuroanatomical substrate of panic disorderH Kaiya
Folia Psychiatrica Et Neurologica Japonica|January 1, 1979
Fine structure of target neurons of antischizophrenic drugs in the neostriatum--ultracytochemical observation of dopamine and acetylcholine interactionH Kaiya
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|May 1, 1972
[Clinical and pathological observations on presenile dementia associated with amyotrophic lateral sclerosis-like symptoms]H Kaiya
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1990
CT findings in schizophreniaH Kaiya
Journal of Clinical Psychopharmacology|October 1, 1987
Prostaglandin E1 treatment of schizophreniaH Kaiya
Rinsho Shinkeigaku = Clinical Neurology|December 1, 1995
[Psycho-social effects of DNA diagnosis]H Kaiya
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1992
Second messenger imbalance hypothesis of schizophreniaH Kaiya
Biological Psychiatry|March 1, 1984
Prostaglandin E1 treatment of schizophreniaH Kaiya
Neuropsychobiology|January 1, 1980
Neuromelanin, neuroleptics and schizophrenia: hypothesis of an interaction between noradrenergic and dopaminergic systemH Kaiya
Schizophrenia Research|July 1, 1991
Prostaglandin E1 suppression of platelet aggregation response in schizophreniaH Kaiya
The American Journal of Psychiatry|January 1, 1990
Another neuroanatomical substrate of panic disorderH Kaiya
Folia Psychiatrica Et Neurologica Japonica|January 1, 1979
Fine structure of target neurons of antischizophrenic drugs in the neostriatum--ultracytochemical observation of dopamine and acetylcholine interactionH Kaiya
Pageof 9